FILTER

FILTERED ARTICLE RESULTS

U.S. Pharmaceuticals: The East Coast

July 25, 2019
From New England to the Mid-Atlantic, a rising tide lifts all boats across the biopharma value chain.

Serialization Regulations Put Packaging Into the Limelight

April 24, 2019
Changing serialization requirements represent an opportunity for packaging companies that are looking to add value for their clients.

Breaking Down Drug Pricing

April 01, 2019
The U.S. biopharmaceuticals industry continues to grapple with the perennial issue of drug pricing.

Servicing Your Every Need

February 27, 2019
Opportunities grow for contract service providers.

Standing Out in the Biotech Crowd: The VC Investment Climate

February 06, 2019
With biotechs now accounting for 70% of clinical trials in the United States, the VC private investment climate is heating up.

The Indispensable Partner: Contract Services

October 31, 2018
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.

From Volume to Value: A Shift in Innovation Focus in the U.S.

August 30, 2018
Precision medicine and the understanding that every patient is different are driving drug discovery.

R&D: Is Innovation Really Happening in China?

August 09, 2018
With an ever-increasing stockpile of innovative technologies and a growing network of talented scientists intently focused on innovation, it will merely be a matter of time before China begins to produce some of the most cutting-edge drugs.

Patient Selection: The Right Drug for the Right Patient

June 06, 2018
By better defining addressable patient populations and more precisely predicting likely individual responses, companies are able to reduce a great deal of risk in their clinical trials.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

MINPER 2019 - Guía Oficial de Inversiones de Perumin

PARTNERS